Simulations Plus Net Income 2011-2025 | SLP
Simulations Plus net income from 2011 to 2025. Net income can be defined as company's net profit or loss after all revenues, income items, and expenses have been accounted for.
|
Simulations Plus Annual Net Income (Millions of US $) |
|
|---|---|
| 2024 | $10 |
| 2023 | $10 |
| 2022 | $12 |
| 2021 | $10 |
| 2020 | $9 |
| 2019 | $9 |
| 2018 | $9 |
| 2017 | $6 |
| 2016 | $5 |
| 2015 | $4 |
| 2014 | $3 |
| 2013 | $3 |
| 2012 | $3 |
| 2011 | $3 |
|
Simulations Plus Quarterly Net Income (Millions of US $) |
|
|---|---|
| 2025-05-31 | $-67 |
| 2025-02-28 | $3 |
| 2024-11-30 | $0 |
| 2024-08-31 | $1 |
| 2024-05-31 | $3 |
| 2024-02-29 | $4 |
| 2023-11-30 | $2 |
| 2023-08-31 | $1 |
| 2023-05-31 | $4 |
| 2023-02-28 | $4 |
| 2022-11-30 | $1 |
| 2022-08-31 | $1 |
| 2022-05-31 | $4 |
| 2022-02-28 | $4 |
| 2021-11-30 | $3 |
| 2021-08-31 | $0 |
| 2021-05-31 | $4 |
| 2021-02-28 | $3 |
| 2020-11-30 | $2 |
| 2020-08-31 | $2 |
| 2020-05-31 | $3 |
| 2020-02-29 | $2 |
| 2019-11-30 | $2 |
| 2019-08-31 | $2 |
| 2019-05-31 | $3 |
| 2019-02-28 | $2 |
| 2018-11-30 | $2 |
| 2018-08-31 | $1 |
| 2018-05-31 | $2 |
| 2018-02-28 | $3 |
| 2017-11-30 | $2 |
| 2017-08-31 | $1 |
| 2017-05-31 | $2 |
| 2017-02-28 | $1 |
| 2016-11-30 | $1 |
| 2016-08-31 | $1 |
| 2016-05-31 | $2 |
| 2016-02-29 | $1 |
| 2015-11-30 | $1 |
| 2015-08-31 | $0 |
| 2015-05-31 | $2 |
| 2015-02-28 | $1 |
| 2014-11-30 | $1 |
| 2014-08-31 | $0 |
| 2014-05-31 | $1 |
| 2014-02-28 | $1 |
| 2013-11-30 | $1 |
| 2013-08-31 | $0 |
| 2013-05-31 | $1 |
| 2013-02-28 | $1 |
| 2012-11-30 | $1 |
| 2012-08-31 | $0 |
| 2012-05-31 | $1 |
| 2012-02-29 | $1 |
| 2011-11-30 | $1 |
| 2011-08-31 | $0 |
| 2011-05-31 | $1 |
| 2011-02-28 | $1 |
| 2010-11-30 | $1 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Computer and Technology | Computer Software | $0.347B | $0.070B |
| Simulations Plus, Inc., is a premier developer of groundbreaking drug discovery and development simulation software, which is licensed to and used in the conduct of drug research by major pharmaceutical and biotechnology companies worldwide. They have two other businesses, Words+, Inc. and FutureLab, which are based on its proprietary software technologies. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Microsoft (MSFT) | United States | $3740.642B | 34.78 |
| Oracle (ORCL) | United States | $620.247B | 44.58 |
| SAP SE (SAP) | Germany | $309.411B | 38.39 |
| Salesforce (CRM) | United States | $228.889B | 29.00 |
| Intuit (INTU) | United States | $181.254B | 42.55 |
| Adobe (ADBE) | United States | $139.645B | 19.93 |
| Cadence Design Systems (CDNS) | United States | $86.013B | 58.41 |
| Synopsys (SNPS) | United States | $73.172B | 41.03 |
| Dassault Systemes SA (DASTY) | France | $37.553B | 22.76 |
| PTC (PTC) | United States | $20.912B | 26.21 |
| SS&C Technologies Holdings (SSNC) | United States | $20.652B | 15.79 |
| Manhattan Associates (MANH) | United States | $10.691B | 48.88 |
| Pegasystems (PEGA) | United States | $9.647B | 40.46 |
| Open Text (OTEX) | Canada | $8.639B | 9.34 |
| Trend Micro (TMICY) | Japan | $7.145B | 28.49 |
| Descartes Systems Group (DSGX) | Canada | $7.078B | 48.70 |
| CommVault Systems (CVLT) | United States | $5.583B | 60.58 |
| ACI Worldwide (ACIW) | United States | $4.862B | 18.07 |
| Blackbaud (BLKB) | United States | $2.883B | 23.36 |
| Sapiens (SPNS) | Israel | $2.420B | 30.86 |
| Progress Software (PRGS) | United States | $1.815B | 9.53 |
| Verint Systems (VRNT) | United States | $1.230B | 16.11 |
| Magic Software Enterprises (MGIC) | Israel | $1.173B | 24.39 |
| PROS Holdings (PRO) | United States | $1.118B | 0.00 |
| Rand Worldwide (RWWI) | United States | $0.504B | 11.27 |
| OptimizeRx (OPRX) | United States | $0.288B | 38.65 |
| Neonode (NEON) | Sweden | $0.038B | 0.00 |
| NetSol Technologies (NTWK) | United States | $0.033B | 70.75 |
| Wetouch Technology (WETH) | $0.030B | 4.06 | |
| Smith Micro Software (SMSI) | United States | $0.014B | 0.00 |
| Global Interactive Technologies (GITS) | South Korea | $0.006B | 0.00 |